2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate

C17H16ClF6N7PPt- — CID 139250627

IUPAC2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate
SMILESC1=CN(c2ncccn2)[CH-]N1Cc1cn(Cc2ccccc2)nn1.Cl[Pt+].F[P-](F)(F)(F)(F)F
InChIInChI=1S/C17H16N7.ClH.F6P.Pt/c1-2-5-15(6-3-1)11-24-13-16(20-21-24)12-22-9-10-23(14-22)17-18-7-4-8-19-17;;1-7(2,3,4,5)6;/h1-10,13-14H,11-12H2;1H;;/q-1;;-1;+2/p-1
InChIKeyOIORDKYRMBXJSO-UHFFFAOYSA-M
MW693.86 g/mol
LogP6.10
Rot. Bonds5

About 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate

2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate (PubChem CID 139250627) has the molecular formula C17H16ClF6N7PPt- and a molecular weight of 693.86 g/mol. Its IUPAC name is 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate.

Molecular Properties

Compound Name2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate
PubChem CID139250627
Molecular FormulaC17H16ClF6N7PPt-
Molecular Weight693.86 g/mol
Exact Mass693.05
IUPAC Name2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate
SMILESC1=CN(c2ncccn2)[CH-]N1Cc1cn(Cc2ccccc2)nn1.Cl[Pt+].F[P-](F)(F)(F)(F)F
InChIInChI=1S/C17H16N7.ClH.F6P.Pt/c1-2-5-15(6-3-1)11-24-13-16(20-21-24)12-22-9-10-23(14-22)17-18-7-4-8-19-17;;1-7(2,3,4,5)6;/h1-10,13-14H,11-12H2;1H;;/q-1;;-1;+2/p-1
InChIKeyOIORDKYRMBXJSO-UHFFFAOYSA-M
XLogP6.10
TPSA62.97 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms33
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500693.86
LogP ≤ 56.10
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate?
The IUPAC name of 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate (CID 139250627) is 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate.
What is the SMILES notation for 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate?
The canonical SMILES for 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate is C1=CN(c2ncccn2)[CH-]N1Cc1cn(Cc2ccccc2)nn1.Cl[Pt+].F[P-](F)(F)(F)(F)F.
What is the InChIKey of 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate?
The InChIKey is OIORDKYRMBXJSO-UHFFFAOYSA-M. The full InChI is InChI=1S/C17H16N7.ClH.F6P.Pt/c1-2-5-15(6-3-1)11-24-13-16(20-21-24)12-22-9-10-23(14-22)17-18-7-4-8-19-17;;1-7(2,3,4,5)6;/h1-10,13-14H,11-12H2;1H;;/q-1;;-1;+2/p-1.
What are the key properties of 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate?
2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate has a molecular weight of 693.86 g/mol, XLogP of 6.10, 5 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[(1-benzyltriazol-4-yl)methyl]-2H-imidazol-2-id-1-yl]pyrimidine;chloroplatinum(1+);hexafluorophosphate is sourced from PubChem (CID 139250627), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).